Omeprazole Delayed-Release Capsules — Class II drug recall D-0026-2022
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2021-10-27, distributed nationwide. CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
| Recall number | D-0026-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2021-10-05 |
| Classified | 2021-10-22 |
| Reported by FDA | 2021-10-27 |
| Terminated | 2022-12-06 |
| Distributed | Nationwide (US) |
| Quantity | 8,976 bottles |
| Reason classes | cgmp |
| NDC | 70000-0232, 70000-0232-01, 70000-0232-02, 70000-0232-03 |
Product
Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium), 24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1
Reason for recall
CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0026-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.